These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 13156131)
1. [Experience with discontinuous heparin in coronary insufficiency]. SAN-CRISTOBAL D; SEPULVEDA G Rev Med Chil; 1953 Nov; 81(11):662-5. PubMed ID: 13156131 [No Abstract] [Full Text] [Related]
2. [Use of heparin in the treatment of coronary diseases; heparin in coronary diseases except infarct]. CAMERON-CURRY V Minerva Med; 1957 Jan; 48(6):183-7. PubMed ID: 13418464 [No Abstract] [Full Text] [Related]
3. [Subcutaneous heparin treatment in cardiosclerosis]. VON AHN B Sven Lakartidn; 1957 Dec; 54(52):3945-55. PubMed ID: 13519397 [No Abstract] [Full Text] [Related]
4. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease. Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576 [TBL] [Abstract][Full Text] [Related]
5. [Effects of heparin in arteriosclerotic coronary diseases]. SCHIROSA G; GUARINI G Atti Soc Ital Cardiol; 1956; 1():119-21. PubMed ID: 13328642 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049 [TBL] [Abstract][Full Text] [Related]
8. A novel technique for coronary bifurcation lesions: cutting balloons, drug-eluting stents and the kissing technique. Wong CB; Hardin S J Invasive Cardiol; 2005 Feb; 17(2):108-10. PubMed ID: 15687538 [No Abstract] [Full Text] [Related]
9. Heparin clearing and inhibition in ischaemic heart disease. NESTEL PJ; MASHFORD ML Clin Sci; 1961 Feb; 20():41-8. PubMed ID: 13728415 [No Abstract] [Full Text] [Related]
10. Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis. Borentain M; Montalescot G; Bouzamondo A; Choussat R; Hulot JS; Lechat P Catheter Cardiovasc Interv; 2005 Jun; 65(2):212-21. PubMed ID: 15900551 [TBL] [Abstract][Full Text] [Related]
11. Direct thrombin inhibitors (part 1 of 2). Arora UK; Dhir M J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538 [No Abstract] [Full Text] [Related]
12. [The use of heparin as a clearing agent in acute and chronic coronary insufficiency]. CARUZZO C; PELLEGRINI A; PAGANO PG; TARTARA D; ANGELINO PF Atti Soc Ital Cardiol; 1962; 22(2)():Comunicazioni 79-80. PubMed ID: 14018997 [No Abstract] [Full Text] [Related]
13. [Experience with the use of heparin in ambular prevention of coronary thrombosis under ambulatory conditions]. Aleĭnikova LI Kardiologiia; 1965; 5(4):50-2. PubMed ID: 5880731 [No Abstract] [Full Text] [Related]
14. Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes. Moser LR; Kalus JS Ann Pharmacother; 2004 Dec; 38(12):2094-104. PubMed ID: 15536140 [TBL] [Abstract][Full Text] [Related]
15. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE). Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G; Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196 [TBL] [Abstract][Full Text] [Related]
16. Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. Sinnaeve PR; Simes J; Yusuf S; Garg J; Mehta S; Eikelboom J; Bittl JA; Serruys P; Topol EJ; Granger CB Eur Heart J; 2005 Nov; 26(22):2396-403. PubMed ID: 16214829 [TBL] [Abstract][Full Text] [Related]
17. Six hour ambulation after elective coronary angioplasty and stenting with 7F guiding catheters ald low dose heparin. Tengiz I; Ercan E; Bozdemir H; Durmaz O; Gurgun C; Nalbantgil I Kardiol Pol; 2003 Feb; 58(2):93-7. PubMed ID: 14504634 [TBL] [Abstract][Full Text] [Related]